COX-2 selective inhibitor

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
Analgesics aromatase inhibitors Celebrex celecoxib class COX-2 COX-2 inhibitors cyclooxygenase cyclooxygenase-2 inhibitor Nonsteroidal Anti-Inflammatory Drugs NSAIDs osteoarthritis primary dysmenorrhea proton pump inhibitor renal rheumatoid arthritis rofecoxib Super Aspirin valdecoxib	The revised guideline recommends the eradication of Helicobacter pylori prior to initiating NSAIDs for pain, and the use of a proton pump inhibitor or misoprostol for gastrointestinal protection in older persons taking nonselective NSAIDs or in patients taking a COX-2 selective inhibitor with aspirin. New pain guideline takes aim at NSAID use in the elderly by Wendling, Patrice / Clinical Psychiatry News There is more long-term safety data from controlled clinical trials, in terms of patient-years on treatment, for Arcoxia than for any other NSAID, including traditional NSAIDs and Cox-2 selective inhibitors. FDA issues non-approvable letter for Arcoxia by Adverse Event Reporting News The MEDAL (Multinational Etoricoxib and Diclofenac Arthritis Long-term) programme provides a randomised comparison of the COX-2 selective inhibitor etoricoxib and the traditional NSAID diclofenac in 34 701 osteoarthritis and rheumatoid arthritis patients followed up for a mean duration of 18 months. Anti-inflammatories, arthritis and gastric outcomes by Farham, Bridget / CME: Your SA Journal of CPD	Cowboy Cowboy Collar Cowden's disease Cowden’s Syndrome Cowdria ruminantium cowdriosis Cowdry Type A Inclusion Cowdry Type B Inclusion cowhage Cowherd cowmen cowpea Cowper's gland Cowper's glands Cowper's syringocele cowperitis cowpox cowside Cowslip COX cox- COX-1 COX-2 COX-2 inhibitor COX-2 inhibitors COX-2 selective inhibitor cox/flexion-distraction coxa coxa adducta coxa magna coxa plana coxa valga coxa vara coxa vara luxans coxal coxal articulation coxal tuber coxalgia coxarthropathy coxcomb Coxiella Coxiella burnetii coxiellosis coxitis coxodynia coxofemoral coxotuberculosis Coxsackie Coxsackie B virus Coxsackie encephalitis Coxsackie virus	COX-2 activity inhibition COX-2 i COX-2 i COX-2 i COX-2 i COX-2 inhibiting drug COX-2 inhibiting drug COX-2 inhibiting drug COX-2 inhibiting drugs COX-2 inhibiting drugs COX-2 inhibiting drugs COX-2 inhibition COX-2 inhibition COX-2 inhibition COX-2 inhibition drug COX-2 inhibition drug COX-2 inhibition drug Cox-2 inhibitor Cox-2 inhibitor Cox-2 inhibitor COX-2 inhibitors COX-2 inhibitors COX-2 inhibitors COX-2 inhibitors COX-2 selective inhbition COX-2 selective inhbition COX-2 selective inhbition COX-2 selective inhibition COX-2 selective inhibition COX-2 selective inhibition COX-2 selective inhibitor COX-2 selective inhibitors COX-2 selective inhibitors COX-2 selective inhibitors Cox-2 selectivity Cox-2 selectivity Cox-2 selectivity COX-2 targeting COX-2 targeting COX-2 targeting COX-2 targeting agent COX-2 targeting agent COX-2 targeting agent COX-2-selective inhibition COX-2-selective inhibition COX-2-selective inhibition COX-2-selective inhibitor COX-2-selective inhibitor COX-2-selective inhibitor COX-2-selective inhibitors COX-2-selective inhibitors COX-2-selective inhibitors Cox-2-selectivity Cox-2-selectivity Cox-2-selectivity cox/flexion-distraction COX1 COX2 COX2 inhibition COX2 inhibition COX2 inhibition

Mentioned in

References in periodicals archive

Medical browser

Full browser

Analgesics
aromatase inhibitors
Celebrex
celecoxib
class
COX-2
COX-2 inhibitors
cyclooxygenase
cyclooxygenase-2 inhibitor
Nonsteroidal Anti-Inflammatory Drugs
NSAIDs
osteoarthritis
primary dysmenorrhea
proton pump inhibitor
renal
rheumatoid arthritis
rofecoxib
Super Aspirin
valdecoxib

The revised guideline recommends the eradication of Helicobacter pylori prior to initiating NSAIDs for pain, and the use of a proton pump inhibitor or misoprostol for gastrointestinal protection in older persons taking nonselective NSAIDs or in patients taking a COX-2 selective inhibitor with aspirin.

New pain guideline takes aim at NSAID use in the elderly by Wendling, Patrice / Clinical Psychiatry News

There is more long-term safety data from controlled clinical trials, in terms of patient-years on treatment, for Arcoxia than for any other NSAID, including traditional NSAIDs and Cox-2 selective inhibitors.

FDA issues non-approvable letter for Arcoxia by Adverse Event Reporting News

The MEDAL (Multinational Etoricoxib and Diclofenac Arthritis Long-term) programme provides a randomised comparison of the COX-2 selective inhibitor etoricoxib and the traditional NSAID diclofenac in 34 701 osteoarthritis and rheumatoid arthritis patients followed up for a mean duration of 18 months.

Anti-inflammatories, arthritis and gastric outcomes by Farham, Bridget / CME: Your SA Journal of CPD

COX-2 activity inhibition
COX-2 i
COX-2 i
COX-2 i
COX-2 i
COX-2 inhibiting drug
COX-2 inhibiting drug
COX-2 inhibiting drug
COX-2 inhibiting drugs
COX-2 inhibiting drugs
COX-2 inhibiting drugs
COX-2 inhibition
COX-2 inhibition
COX-2 inhibition
COX-2 inhibition drug
COX-2 inhibition drug
COX-2 inhibition drug
Cox-2 inhibitor
Cox-2 inhibitor
Cox-2 inhibitor
COX-2 inhibitors
COX-2 inhibitors
COX-2 inhibitors
COX-2 inhibitors
COX-2 selective inhbition
COX-2 selective inhbition
COX-2 selective inhbition
COX-2 selective inhibition
COX-2 selective inhibition
COX-2 selective inhibition

COX-2 selective inhibitor

COX-2 inhibitor (redirected from COX-2 selective inhibitor)

COX-2 inhibitor
(redirected from COX-2 selective inhibitor)